Higher efficacy of pegylated interferon-α2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy-Reference-Cited by-同舟云学术

Higher efficacy of pegylated interferon-α2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy

Published:2018-03-12 Issue:6 Volume:48 Page:451-458
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Jindal Ankur¹,Vyas Ashish Kumar²,Kumar Devesh³,Kumar Guresh³,Sharma Manoj Kumar¹,Sarin Shiv Kumar¹

Affiliation:

1. Department of Hepatology; Institute of Liver and Biliary Sciences; New Delhi India

2. Departments of Molecular and Cellular Medicine; Institute of Liver and Biliary Sciences; New Delhi India

3. Department of Clinical Research; Institute of Liver and Biliary Sciences; New Delhi India

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13049/fullpdf

Reference15 articles.

1. Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance;Yang;Emerg Microbes Infect,2014

2. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B;Liaw;Hepatol Int,2009

3. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

4. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?;Kao;Liver Int,2014

5. Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels;Chen;J Viral Hepat,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Antiviral Therapy for Hepatitis B Cirrhosis in the Compensated Stage;Advances in Clinical Medicine;2024

2. Clinical efficacy of treated chronic hepatitis B patients with low-level viremia;2023-09-25

3. Letter: sPD ‐1 as a predictor for HBsAg seroconversion—shed light on inactive carriers with chronic hepatsitis B;Alimentary Pharmacology & Therapeutics;2022-03-31

4. Effect of Pegylated Interferon Plus Tenofovir Combination on Higher Hepatitis B Surface Antigen Loss in Treatment-naive Patients With Hepatitis B e Antigen -positive Chronic Hepatitis B: A Real-world Experience;Clinical Therapeutics;2021-03

5. A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study;Journal of Infection and Chemotherapy;2020-12